Sigyn Therapeutics reported cash from operations of -$0.20M and free cash flow of -$0.20M for the quarter ended Sep 2025, down 21.7% year over year. This cash flow statement covers 36 quarters of results from Mar 2016 through Sep 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||
| Net Income | -0.45M | -0.46M | -0.65M | -0.67M | -1.23M | -0.68M | -0.67M | -0.73M | -0.86M | -1.34M | -0.72M | -0.91M | -1.18M | -0.76M | -0.86M | -1.20M | -0.52M | -0.67M | -1.45M | -0.58M | ||||||||||||||||
| Depreciation and DepletionDep. & Depletion | -691.00 | 344.00 | 503.00 | 432.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||||||||||||
| Share-based CompensationStock Comp. | 0.08M | 0.08M | 0.05M | 0.04M | 0.04M | 0.04M | 0.04M | 0.10M | 0.04M | 0.04M | 0.04M | 0.04M | 0.05M | 0.05M | 0.05M | |||||||||||||||||||||
| Cash from OperationsCash from Ops. | -0.28M | -0.27M | -0.41M | -0.54M | -0.55M | -0.46M | -0.39M | -0.52M | -0.45M | -0.56M | -0.33M | -0.36M | -0.13M | -0.24M | -0.18M | -0.16M | -0.29M | -0.29M | -0.15M | -0.20M | ||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.01M | 0.01M | 0.00M | 899.00 | 900.00 | 900.00 | 900.00 | 900.00 | 900.00 | 900.00 | 900.00 | 300.00 | ||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | -691.00 | 344.00 | 503.00 | 432.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | ||||||||||||||||||||||||||||||||||||
| Change in InventoryChange Inventory | ||||||||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.01M | 0.03M | -0.00M | -0.01M | 0.01M | 0.16M | 0.10M | 0.01M | 0.02M | -0.06M | 0.07M | 0.02M | 0.16M | 0.07M | -0.04M | 0.12M | -0.00M | 0.06M | 0.06M | 0.04M | ||||||||||||||||
| Change in TaxesChange Taxes | 0.04M | 0.01M | 13.00 | -0.02M | -0.04M | -0.04M | 0.01M | 0.15M | 0.22M | 0.32M | 0.29M | 0.42M | 0.27M | 0.11M | 0.14M | 0.18M | 0.09M | |||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 139.00 | -0.03M | 0.01M | 0.04M | -0.04M | 0.00M | 0.03M | 0.02M | -875.00 | 0.00M | -0.00M | -0.01M | 0.01M | -0.05M | -0.00M | -0.00M | -0.00M | |||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.00M | 0.02M | 0.01M | 1.00 | ||||||||||||||||||||||||||||||||
| Change in IntangiblesChange Intangibless | ||||||||||||||||||||||||||||||||||||
| Divestments | ||||||||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.00M | -0.02M | -0.01M | -1.00 | ||||||||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 10.00 | 0.20M | 1.46M | 0.40M | 0.20M | 0.32M | 0.55M | 0.43M | 0.88M | 0.03M | 0.41M | 0.07M | 0.26M | 0.20M | 0.27M | 0.14M | 0.30M | 0.14M | 0.28M | |||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||
| Change in Cash | -0.28M | -0.08M | 1.05M | -0.56M | -0.16M | -0.26M | -0.07M | 0.02M | -0.02M | 0.31M | -0.30M | 0.04M | -0.05M | 0.02M | 0.02M | 0.11M | -0.15M | 751.00 | -0.01M | 0.09M | ||||||||||||||||
| Free Cash FlowFCF | -0.28M | -0.28M | -0.41M | -0.56M | -0.56M | -0.46M | -0.39M | -0.52M | -0.45M | -0.56M | -0.33M | -0.36M | -0.13M | -0.24M | -0.18M | -0.16M | -0.29M | -0.29M | -0.15M | -0.20M | ||||||||||||||||
| Net Cash FlowNCF | -0.28M | -0.08M | 1.05M | -0.56M | -0.16M | -0.26M | -0.07M | 0.02M | -0.02M | 0.31M | -0.30M | 0.04M | -0.05M | 0.02M | 0.02M | 0.11M | -0.15M | 751.00 | -0.01M | 0.09M |
Pull Sigyn Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=SIGY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "SIGY", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=SIGY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();